Tailored Bacterial Magnetic Nanoparticles For Biomedical Imaging
This project aims to revolutionize biomedical applications by developing high-quality, biocompatible magnetic iron oxide nanoparticles using genetically engineered microbes for enhanced functionality and sustainability.
Projectdetails
Introduction
Of tremendous biomedical and clinical interest are magnetic iron oxide nanoparticles (MNP) that can be tailored to fulfill specific functions, for instance as actuated drug carriers, tracers for magnetic imaging modalities, or heat generators in magnetic hyperthermia for cancer therapy.
Challenges in Current Applications
However, their use in real-world applications has been hampered by:
- Lack of precise size control and magnetic tunability
- Poor biocompatibility associated with their conventional synthesis
Proposed Solution
I propose a step-change approach for the light-powered bioproduction of high-quality magnetic nanoparticles by novel synthetic microbes generated in ERC-AdG Syntomagx, crafted precisely for their use in biomedical applications.
Advantages of Novel Bacterial MNP
Compared to commercial, chemically synthesized MNP, these novel bacterial MNP are expected to exhibit superior applicability and versatility, owing to:
- Genetically tuned and uniform physicochemical and magnetic characteristics
- High cost-efficiency
- Sustainable manufacturing conditions
Production and Assessment
First, bacterial production and purification of the particles will be set up at large lab scale. In addition, their anticipated superior biocompatibility will be thoroughly assessed.
Collaboration and Demonstration
Then, we will explore and demonstrate their performance in collaboration with various biomedical end users. As proof-of-concept, we will deliver a formulation of bacterial MNP tailored as potent tracers in high-resolution magnetic particle imaging (MPI).
Long-term Goals
With respect to the long-term goal of future commercial exploitation, we will explore patenting options and thoroughly assess the demand for such high-quality biogenic MNP.
Vision for the Future
I envision that our idea will revolutionize the biomedical MNP market by opening it for the wealth of genetically tailored and highly functionalized bacterial MNP, suitable for a wide range of applications.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 150.000 |
Totale projectbegroting | € 150.000 |
Tijdlijn
Startdatum | 1-11-2023 |
Einddatum | 30-4-2025 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- UNIVERSITAT BAYREUTHpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Nano-Biological Contrast Agent Platform for MRI ImagingNANO-IMAGING aims to develop customizable, safe, and tissue-specific MRI contrast agents using metal-protein hybrid nanostructures to enhance diagnostic imaging efficiency. | ERC Proof of... | € 150.000 | 2022 | Details |
MAGNETIC HYPERTHERMIA FOR METASTASIZED TUMOR TREATMENT AND REMOTE MANIPULATION OF MICRODEVICESThe GIULIa project aims to enhance cancer treatment by using magnetic nanoparticles in natural killer cells for targeted hyperthermia and developing magnetic microdevices for precise drug delivery. | ERC Consolid... | € 2.993.750 | 2023 | Details |
MAGNIFICO-Pre-commercialization of multifunctional targeted MRI-contrast enhancing agents for brain researchThis project aims to enhance MRI's capabilities for brain disease research by developing targeted fluorescent contrast agents and engineering cells for improved in vivo imaging. | ERC Proof of... | € 150.000 | 2022 | Details |
Bulk rare earth free permanent magnetsThe project aims to develop a high-performance, rare-earth-free MnBi permanent magnet using a novel processing route for large-scale industrial applications, enhancing temperature stability and energy efficiency. | ERC Proof of... | € 150.000 | 2022 | Details |
A companion magnetic sensor for in operando detection of magnetic biosynthesis in cancer and neurodegenerative modelsThe BioMag PoC project aims to develop a sensitive magnetic sensor for real-time monitoring of intracellular magnetic iron biosynthesis, potentially leading to novel therapies for cancer and Alzheimer's. | ERC Proof of... | € 150.000 | 2022 | Details |
Nano-Biological Contrast Agent Platform for MRI Imaging
NANO-IMAGING aims to develop customizable, safe, and tissue-specific MRI contrast agents using metal-protein hybrid nanostructures to enhance diagnostic imaging efficiency.
MAGNETIC HYPERTHERMIA FOR METASTASIZED TUMOR TREATMENT AND REMOTE MANIPULATION OF MICRODEVICES
The GIULIa project aims to enhance cancer treatment by using magnetic nanoparticles in natural killer cells for targeted hyperthermia and developing magnetic microdevices for precise drug delivery.
MAGNIFICO-Pre-commercialization of multifunctional targeted MRI-contrast enhancing agents for brain research
This project aims to enhance MRI's capabilities for brain disease research by developing targeted fluorescent contrast agents and engineering cells for improved in vivo imaging.
Bulk rare earth free permanent magnets
The project aims to develop a high-performance, rare-earth-free MnBi permanent magnet using a novel processing route for large-scale industrial applications, enhancing temperature stability and energy efficiency.
A companion magnetic sensor for in operando detection of magnetic biosynthesis in cancer and neurodegenerative models
The BioMag PoC project aims to develop a sensitive magnetic sensor for real-time monitoring of intracellular magnetic iron biosynthesis, potentially leading to novel therapies for cancer and Alzheimer's.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Single Molecule Nuclear Magnetic Resonance Microscopy for Complex Spin SystemsThis project aims to enhance NMR sensitivity to single molecules using scanning probe microscopy, enabling groundbreaking insights in nanotechnology and impacting NMR and SPM markets. | EIC Pathfinder | € 2.994.409 | 2023 | Details |
A synaptic mechanogenetic technology to repair brain connectivityDeveloping a mechanogenetic technology using magnetic nanoparticles to non-invasively regulate neural circuits for treating treatment-resistant brain disorders like stroke and epilepsy. | EIC Pathfinder | € 3.543.967 | 2023 | Details |
Targeted Nano-formulations for Treatment of MRSA: A multicomponent platform for nano-formulated treatment of resistant microbial infectionsLeadToTreat aims to develop targeted nano-formulations for treating MRSA infections by co-delivering novel low-drugability compounds and synergistic antibiotic combinations. | EIC Pathfinder | € 2.665.564 | 2022 | Details |
MagnetoElectric and Ultrasonic Technology for Advanced BRAIN modulationMETA-BRAIN aims to develop non-invasive, precise control of brain activity using magnetoelectric nanoarchitectures and ultrasonic technologies, enhancing treatment for neurological disorders. | EIC Pathfinder | € 2.987.655 | 2024 | Details |
NanoBiCar: A novel immunotherapy for infectious diseasesNanoBiCar aims to revolutionize bacterial infection treatment through innovative mRNA-based immunotherapy, targeting Mycobacterium tuberculosis to eliminate drug-resistant strains without generating resistance. | EIC Pathfinder | € 2.999.101 | 2025 | Details |
Single Molecule Nuclear Magnetic Resonance Microscopy for Complex Spin Systems
This project aims to enhance NMR sensitivity to single molecules using scanning probe microscopy, enabling groundbreaking insights in nanotechnology and impacting NMR and SPM markets.
A synaptic mechanogenetic technology to repair brain connectivity
Developing a mechanogenetic technology using magnetic nanoparticles to non-invasively regulate neural circuits for treating treatment-resistant brain disorders like stroke and epilepsy.
Targeted Nano-formulations for Treatment of MRSA: A multicomponent platform for nano-formulated treatment of resistant microbial infections
LeadToTreat aims to develop targeted nano-formulations for treating MRSA infections by co-delivering novel low-drugability compounds and synergistic antibiotic combinations.
MagnetoElectric and Ultrasonic Technology for Advanced BRAIN modulation
META-BRAIN aims to develop non-invasive, precise control of brain activity using magnetoelectric nanoarchitectures and ultrasonic technologies, enhancing treatment for neurological disorders.
NanoBiCar: A novel immunotherapy for infectious diseases
NanoBiCar aims to revolutionize bacterial infection treatment through innovative mRNA-based immunotherapy, targeting Mycobacterium tuberculosis to eliminate drug-resistant strains without generating resistance.